PRQR logo

ProQR Therapeutics NV (PRQR)

Profile

Full Name

ProQR Therapeutics N.V.

Ticker Symbol

PRQR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Netherlands

IPO

September 18, 2014

Indexes

Not included

Website

http://www.proqr.com

Employees

166

Key Details

Price

$1.15(-3.78%)

Market cap

$120.47M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$20.46M(+190.15% YoY)

Annual EPS

-$0.35(+8.58% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.15
PRQR price is $1.15

30-Day Relative Volume

0.83
PRQR 30-day relative volume is 0.83

Price Performance

Price Today change

-3.78%
PRQR price is down -3.78% today

Price YTD change

-56.79%
PRQR price is down -56.79% since January 1st

Price 1-year change

-42.75%
PRQR price is down -42.75% year-on-year

Price 3-year change

+45.49%
PRQR price is up +45.49% over the past 3 years

Price Range

Price All-time high

$27.60
PRQR price is currently -95.85% below its historical high of $27.60

Price 3-year low

$0.53
PRQR price is currently +116.04% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$120.47M
PRQR market capitalization is $120.47 million

Market cap 3-year change

+114.5%
PRQR market capitalization is up +114.5% over the past 3 years

Market cap All-time high

$867.23M
PRQR market capitalization is currently -86.11% below its historical high of $867.23 million

Market cap sector rank

50.74%
PRQR market capitalization is higher than 50.74% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+28.84%
PRQR shares outstanding is up +28.84% year-on-year

Shares Outstanding 3-Year Change

+47.43%
PRQR shares outstanding is up +47.43% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.10
PRQR beta is 1.10

200-day SMA

$2.33
PRQR price is currently -50.85% below its 200-day simple moving average

50-day SMA

$1.84
PRQR price is currently -37.89% below its 50-day simple moving average

RSI

30.30
PRQR 14-day relative strength index is 30.30

Volume

0.83
PRQR 30-day relative volume is 0.83

ATR

$0.13
PRQR average true range is $0.13

10-day Historical Volatility

84.06%
PRQR 10-day historical volatility is 84.06%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$20.46M
PRQR annual revenue is $20.46 million

Revenue Analysts estimate

$19.00M
PRQR annual revenue is currently +7.67% higher than the consensus analysts' forecast

Revenue 1-year change

+190.15%
PRQR annual revenue is up +190.15% year-on-year

Revenue Sector rank

34.97%
PRQR annual revenue is higher than 34.97% of companies in Healthcare sector

EPS

EPS

-$0.35
PRQR annual earnings per share is -$0.35

EPS Analysts estimate

-$0.67
PRQR annual earnings per share is currently -48.30% lower than the consensus analysts' forecast

EPS 1-year change

+8.58%
PRQR annual earnings per share is up +8.58% year-on-year

EPS Sector rank

72.66%
PRQR annual earnings per share is higher than 72.66% of companies in Healthcare sector

Profit

Gross profit

-
PRQR annual gross profit value is unknown

Gross margin

-
PRQR annual gross profit margin value is unknown

Operating profit

-$32.98M
PRQR annual operating income is -$32.98 million

Operating margin

-161.18%
PRQR annual operating profit margin is -161.18%

Net income

-$30.05M
PRQR annual net profit is -$30.05 million

Net margin

-146.86%
PRQR annual net profit margin is -146.86%

Expenses

Total expenses

$53.44M
PRQR annual total expenses is $53.44 million

Operating expenses

$53.44M
PRQR annual total operating expenses is $53.44 million

Cost of goods sold

-
PRQR annual cost of goods sold value is unknown

Selling, general & administrative expenses

$14.79M
PRQR annual SGA is $14.79 million

Depreciation and amortization

$2.99M
PRQR annual depreciation & amortization is $2.99 million

Interest expense

$1.17M
PRQR annual interest expense is $1.17 million

Income tax

-$213.20K
PRQR annual income tax is -$213.20 thousand

EBIT & EBITDA

EBIT

-$29.10M
PRQR annual earnings before interest & taxes is -$29.10 million

EBITDA

-$26.11M
PRQR annual EBITDA is -$26.11 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$174.77M
PRQR annual total assets is $174.77 million

Non current assets

$14.69M
PRQR annual long term assets is $14.69 million

Current assets

$160.09M
PRQR annual total current assets is $160.09 million

Cash and cash equivalents

$155.47M
PRQR annual cash & cash equivalents is $155.47 million

Accounts receivable

-
PRQR annual accounts receivable value is unknown

Inventory

-
PRQR annual inventory value is unknown

Liabilities

Total liabilities

$82.62M
PRQR annual total liabilities is $82.62 million

Long term liabilities

$42.14M
PRQR annual total long term liabilities is $42.14 million

Current liabilities

$40.48M
PRQR annual total current liabilities is $40.48 million

Accounts payable

$16.60K
PRQR annual accounts payable is $16.60 thousand

Debt

Total debt

$17.91M
PRQR annual total debt is $17.91 million

Total debt 1-year change

-17.88%
PRQR annual total debt is down -17.88% year-on-year

Long term debt

$11.52M
PRQR annual long term debt is $11.52 million

Short term debt

$6.40M
PRQR annual short term debt is $6.40 million

Equity & Capital

Shareholders equity

$92.15M
PRQR annual stockholders equity is $92.15 million

Book value

$92.15M
PRQR annual book value is $92.15 million

Retained earnings

-$444.49M
PRQR annual retained earnings is -$444.49 million

Working capital

$119.61M
PRQR annual working capital is $119.61 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$39.39M
PRQR annual cash flow from operations is -$39.39 million

Cash from operations 1-year change

-268.85%
PRQR annual cash flow from operations is down -268.85% year-on-year

Cash from investing

-$4.41M
PRQR annual cash flow from investing activities is -$4.41 million

Cash from investing 1-year change

-195.19%
PRQR annual cash flow from investing activities is down -195.19% year-on-year

Cash from financing

$76.06M
PRQR annual cash flow from financing activities is $76.06 million

Cash from financing 1-year change

+3188.36%
PRQR annual cash flow from financing activities is up +3188.36% year-on-year

CAPEX

CAPEX

$1.53M
PRQR annual capital expenditures is $1.53 million

CAPEX 1-year change

+3.4%
PRQR annual capital expenditures is up +3.4% year-on-year

Free Cash Flow

Free cash flow

-$40.92M
PRQR annual free cash flow is -$40.92 million

Free cash flow 1-year change

-287.35%
PRQR annual free cash flow is down -287.35% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
PRQR annual gross profit margin value is unknown

Operating margin

-161.18%
PRQR annual operating profit margin is -161.18%

Net margin

-146.86%
PRQR annual net profit margin is -146.86%

ROA & ROE

ROA

-18.37%
PRQR annual return on assets is -18.37%

ROE

-43.58%
PRQR annual return on equity is -43.58%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
PRQR price to earnings ratio value is unknown

PE ratio Sector rank

-
PRQR price to earnings ratio is unknown

PB Ratio

PB ratio

1.31
PRQR price to book ratio is 1.31

PB ratio Sector rank

51.52%
PRQR price to book ratio is higher than 51.52% of companies in Healthcare sector

PS Ratio

PS ratio

5.89
PRQR price to sales ratio is 5.89

PS ratio Sector rank

69.87%
PRQR price to sales ratio is higher than 69.87% of companies in Healthcare sector

Enterprise value

Enterprise value

-$17.09M
PRQR enterprise value is -$17.09 million

Enterprise value Sector rank

3.47%
PRQR enterprise value is higher than 3.47% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.65
PRQR EV/EBITDA is 0.65

EV/EBITDA Sector rank

73.19%
PRQR EV/EBITDA is higher than 73.19% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.95
PRQR annual current ratio is 3.95

Quick ratio

-
PRQR annual quick ratio value is unknown

Leverage

Debt to equity

0.05
PRQR annual debt to equity ratio is 0.05

Interest coverage ratio

-24.96
PRQR annual interest coverage ratio is -24.96

Risk & Stability

Piotroski F-Score

-
PRQR piotroski f-score value is unknown

Altman Z-Score

-2.30
PRQR altman z-score is -2.30

Analyst ratings

Recent major analysts updates

Mar 14, 25 HC Wainwright & Co.
Buy
Mar 14, 25 Chardan Capital
Buy
Feb 12, 25 Jones Trading
Buy
Dec 12, 24 JMP Securities
Market Outperform
Dec 12, 24 HC Wainwright & Co.
Buy
Dec 12, 24 Chardan Capital
Buy
Nov 8, 24 HC Wainwright & Co.
Buy
Oct 29, 24 Raymond James
Strong Buy
May 10, 24 HC Wainwright & Co.
Buy
May 10, 24 Chardan Capital
Buy

Institutional Ownership

Similar stocks

SEER logo
Seer (SEER)
KRRO logo
Korro Bio (KRRO)
SERA logo
Sera Prognostics (SERA)
CHRS logo
Coherus BioSciences (CHRS)
THTX logo
Theratechnologies (THTX)
FATE logo
Fate Therapeutics (FATE)
KOD logo
Kodiak Sciences (KOD)
CGEN logo
Compugen (CGEN)
NKTX logo
Nkarta (NKTX)
  • What is the ticker symbol for ProQR Therapeutics NV?
  • Does ProQR Therapeutics NV pay dividends?
  • What sector is ProQR Therapeutics NV in?
  • What industry is ProQR Therapeutics NV in?
  • What country is ProQR Therapeutics NV based in?
  • When did ProQR Therapeutics NV go public?
  • Is ProQR Therapeutics NV in the S&P 500?
  • Is ProQR Therapeutics NV in the NASDAQ 100?
  • Is ProQR Therapeutics NV in the Dow Jones?
  • When was ProQR Therapeutics NV's last earnings report?
  • When does ProQR Therapeutics NV report earnings?

What is the ticker symbol for ProQR Therapeutics NV?

The ticker symbol for ProQR Therapeutics NV is NASDAQ:PRQR

Does ProQR Therapeutics NV pay dividends?

No, ProQR Therapeutics NV does not pay dividends

What sector is ProQR Therapeutics NV in?

ProQR Therapeutics NV is in the Healthcare sector

What industry is ProQR Therapeutics NV in?

ProQR Therapeutics NV is in the Biotechnology industry

What country is ProQR Therapeutics NV based in?

ProQR Therapeutics NV is headquartered in Netherlands

When did ProQR Therapeutics NV go public?

ProQR Therapeutics NV's initial public offering (IPO) was on September 18, 2014

Is ProQR Therapeutics NV in the S&P 500?

No, ProQR Therapeutics NV is not included in the S&P 500 index

Is ProQR Therapeutics NV in the NASDAQ 100?

No, ProQR Therapeutics NV is not included in the NASDAQ 100 index

Is ProQR Therapeutics NV in the Dow Jones?

No, ProQR Therapeutics NV is not included in the Dow Jones index

When was ProQR Therapeutics NV's last earnings report?

ProQR Therapeutics NV's most recent earnings report was on Mar 13, 2025

When does ProQR Therapeutics NV report earnings?

The next expected earnings date for ProQR Therapeutics NV is May 9, 2025
On this page